PLSM

6-K - Pulsenmore Ltd. (0002064764) (Filer)

20-F - Pulsenmore Ltd. (0002064764) (Filer)

Management to Host Conference Call and Webcast today at 8:30am ET to Discuss Results and Provide Business Update OMER, Israel, March 30, 2026  /PRNewswire/ – Pulsenmore Ltd. (NASDAQ:PLSM) (TASE: PLSM), a pioneer in home ultrasound technology, today announced financial results for the full year ended December 31, 2025.  Full-Year 2025 Financial HighlightsFull year revenue of $12.5 million, representing a 374% increase compared to 2024, including a one-time revenue contribution of $9.6 million related to the GE settlement discussed below.Net loss improved significantly to $5 million, compared to $10 million in 2024.$21.7 million in total liquid assets (including $7 million in cash and cash equ

OMER, Israel, March 25, 2026 /PRNewswire/ -- Pulsenmore Ltd. (NASDAQ:PLSM) (TASE: PLSM), a pioneer in home ultrasound technology, today announced that it will release its financial results for full year 2025 on March 30, 2026 at 8:30 a.m. EST. The Company will host a conference call and webcast to discuss its financial results, business highlights, and recent progress.Conference Call & Webcast DetailsDate: March 30, 2026Time: 8:30 a.m. Eastern Time/ 3:30 p.m. Israel TimeWebcast: https://teams.microsoft.com/meet/3845461353556?p=fcIpXc4mErwEAqo3IrReplay: The meeting will be record

3 - Pulsenmore Ltd. (0002064764) (Issuer)

3 - Pulsenmore Ltd. (0002064764) (Issuer)

3 - Pulsenmore Ltd. (0002064764) (Issuer)

3 - Pulsenmore Ltd. (0002064764) (Issuer)

3 - Pulsenmore Ltd. (0002064764) (Issuer)

3 - Pulsenmore Ltd. (0002064764) (Issuer)

3 - Pulsenmore Ltd. (0002064764) (Issuer)

3 - Pulsenmore Ltd. (0002064764) (Issuer)

3 - Pulsenmore Ltd. (0002064764) (Issuer)

3 - Pulsenmore Ltd. (0002064764) (Issuer)

6-K - Pulsenmore Ltd. (0002064764) (Filer)

6-K - Pulsenmore Ltd. (0002064764) (Filer)

OMER, Israel, Feb. 9, 2026 /PRNewswire/ -- Pulsenmore Ltd. (NASDAQ:PLSM) (TASE: PLSM), a pioneer in home ultrasound technology, today announced a new commercial engagement with TLC Perinatal PA, a maternal-fetal medicine and women's ultrasound practice in Maryland, as part of its growing U.S. rollout. In early February 2026, Pulsenmore, through its U.S. subsidiary, entered into a services agreement with TLC Perinatal PA, which operates in Silver Spring and Germantown, Maryland. Under the agreement, TLC Perinatal will incorporate Pulsenmore's Early Screening (ES) home ultrasound services into its care model, allowing patients to perform ultrasound scans at home as part of a physician-directe

6-K - Pulsenmore Ltd. (0002064764) (Filer)

OMER, Israel, Feb. 2, 2026 /PRNewswire/ -- Pulsenmore Ltd. (NASDAQ:PLSM) (TASE: PLSM), a pioneer in home ultrasound technology, today announced a first commercial engagement with a medical center in the United States, following receipt of FDA approval for its home pregnancy ultrasound product. At the end of January 2026, the Company (through its subsidiary) entered into a services agreement with the Center for Fetal Medicine & Women's Ultrasound, a fetal medicine and women's ultrasound center located in LA California (the "CFFM"). Under the agreement, CFFM will purchase Pulsen

SEC STAFF ACTION - Pulsenmore Ltd. (0002064764) (Filer)

6-K - Pulsenmore Ltd. (0002064764) (Filer)

Commercial agreement potentially valued at approximately $4.5 million over five years following 18 month pilot; Service to be deployed via Beilinson NEXT, Beilinson's virtual hospital RAMAT GAN, Israel, Jan. 26, 2026 /PRNewswire/ -- Pulsenmore Ltd. (NASDAQ:PLSM) (TASE: PLSM), a global leader in connected home ultrasound technology, today announced an additional strategic commercial agreement with Clalit Health Services, Israel's largest health maintenance organization (HMO), to supply Pulsenmore FC, a new at-home ultrasound solution designed for remote follicular monitoring in women undergoing fertility care (IVF and fertility preservation). The agreement is potentially valued at approximate